Concepedia

Hui-Ju Tseng

HT

11

Publications

242

Citations

10

H-Index

2017

Active since

Affiliations

Taipei Medical University(Current)

Chinese University of Hong Kong, Shenzhen

Wan Fang Hospital

National Taiwan University

University of Southern California

Hui-Ju Tseng is an author at Taipei Medical University specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2017–2023

11

Publications

11

Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease

Hui-Ju Tseng, Mei-Hsiang Lin, Young‐Ji Shiao et al. · European Journal of Medicinal Chemistry · 2020 · 53 citations · Full text

, , +11

Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach

Kai‐Cheng Hsu, Changyi Liu, Tony Eight Lin et al. · Scientific Reports · 2017 · 51 citations · Full text

Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia

Liang‐Chieh Chen, Han-Li Huang, Wei‐Chun HuangFu et al. · Journal of Natural Products · 2020 · 26 citations · Full text

Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia

Shih‐Chung Yen, Liang‐Chieh Chen, Han-Li Huang et al. · Journal of Natural Products · 2021 · 18 citations · Full text

Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors

Kai‐Cheng Hsu, Jung-Chun Chu, Hui-Ju Tseng et al. · European Journal of Medicinal Chemistry · 2021 · 18 citations · Full text

, , +6

Rows per page

1–5 of 11